Literature DB >> 15684906

Central vascular access devices in oncology and hematology considered from a different point of view: how do patients experience their vascular access ports?

Godelieve A Goossens1, Marc Vrebos, Marguerite Stas, Ivo De Wever, Lutgarde Frederickx.   

Abstract

BACKGROUND: Oncology patients require long-term vascular access, but the subjective experience of having a port in daily life is not well studied.
METHODS: In a prospective study, patients at an outpatient clinic filled out a questionnaire. INSTRUMENT: The questionnaire consisted of four questions.
RESULTS: The top three reported benefits of having a port were (1) no more peripheral venipunctures, (2) greater convenience, and (3) arms left free for activities of daily living. Patients disliked the visibility of ports and complained about site soreness.
CONCLUSIONS: Good nursing care includes the ability to provide optimal care and maintenance of the vascular access device, but understanding the patients' point of view is an added value.

Entities:  

Mesh:

Year:  2005        PMID: 15684906     DOI: 10.1097/00129804-200501000-00008

Source DB:  PubMed          Journal:  J Infus Nurs        ISSN: 1533-1458


  8 in total

1.  Improving cancer patients' knowledge about totally implantable access port: a randomized controlled trial.

Authors:  Michela Piredda; Valentina Biagioli; Diana Giannarelli; Daniele Incletoli; Francesca Grieco; Massimiliano Carassiti; Maria Grazia De Marinis
Journal:  Support Care Cancer       Date:  2015-07-24       Impact factor: 3.603

Review 2.  Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved?

Authors:  Roberto Biffi; Adriana Toro; Simonetta Pozzi; Isidoro Di Carlo
Journal:  Support Care Cancer       Date:  2014-06       Impact factor: 3.603

3.  No impact of central venous insertion site on oncology patients' quality of life and psychological distress. A randomized three-arm trial.

Authors:  Roberto Biffi; Franco Orsi; Simonetta Pozzi; Andrea Maldifassi; Davide Radice; Nicole Rotmensz; Maria Giulia Zampino; Nicola Fazio; Giulia Peruzzotti; Florence Didier
Journal:  Support Care Cancer       Date:  2010-08-28       Impact factor: 3.603

4.  Patients' perceptions of having a central venous catheter or a totally implantable subcutaneous port system-results from a randomised study in acute leukaemia.

Authors:  Eva Johansson; Per Engervall; Hjördis Björvell; Robert Hast; Magnus Björkholm
Journal:  Support Care Cancer       Date:  2008-05-01       Impact factor: 3.603

5.  Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.

Authors:  Kul Ranjan Singh; Gaurav Agarwal; Gitika Nanda; Gyan Chand; Anjali Mishra; Amit Agarwal; Ashok K Verma; Saroj K Mishra; Puneet Goyal
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

6.  Validation of a questionnaire of knowledge and attitudes about the subcutaneous venous reservoir in nursing.

Authors:  Roberto Raña-Rocha; Ignacio López-de-Ullibarri; María-Jesús Movilla-Fernández; Carmen Coronado Carvajal
Journal:  Rev Lat Am Enfermagem       Date:  2020-04-17

7.  Evidence on port-locking with heparin versus saline in patients with cancer not receiving chemotherapy: A randomized clinical trial.

Authors:  Melania Cia-Arriaza; Sandra Cabrera-Jaime; Rosario Cano-Soria; Mireia Manzano-Castro; Margarita Domínguez-Gómez; Dolores M Prieto-Arenas; Angeles Benito-Yagüe; Adela Sánchez-Martín; Cristina González-Alonso; Paz Fernández-Ortega
Journal:  Asia Pac J Oncol Nurs       Date:  2022-05-21

8.  Tailored approach to the choice of long-term vascular access in breast cancer patients.

Authors:  Hyangkyoung Kim; Sukyung Kwon; Soo Mi Son; Eunseon Jeong; Jang-Yong Kim
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.